Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Screening, referrals needed for overlooked ‘third pillar’ of PCOS: Psychosocial symptoms Regina Schaffer
• Canagliflozin may reduce albuminuria, eGFR decline in patients with type 2 diabetes Shawn M. Carter
• Care partners of deaf and hard-of-hearing people with diabetes face unique challenges Michael Monostra
• Clinicians ‘should be open’ to menopausal hormone therapy beyond age 65 years Erin T. Welsh, MA
• Digital access key to boosting diabetes self-management education uptake for older adults Michael Monostra
• Eating more oats, fruits in early childhood may raise risk for type 1 diabetes Michael Monostra
• Exposure to cholinergic compounds, personal care products may lead to early puberty Michael Monostra
• FDA approves next-generation CGM with two-step insertion process
• FDA clears implantable CGM with sensor that lasts up to 1 year
• FDA clears tubeless automated insulin delivery system for adults with type 2 diabetes
• FTC files administrative complaint vs. PBMs alleging artificially inflated insulin prices Erik Swain
• Hormonal contraceptive gel for men suppresses sperm production by week 8 Jill Rollet
• Hormone therapy use among menopausal women continues to decline, despite proven safety Regina Schaffer
• Liraglutide 3 mg reduces BMI for children with obesity aged 6 to 11 years Michael Monostra
• Medicare announces price cuts for 10 drugs in first round of drug price negotiations Michael Monostra
• New oral obesity drug safe, linked to weight loss in first-in-human study Erik Swain
• Off-label semaglutide, tirzepatide lower HbA1c and body weight in type 1 diabetes Michael Monostra
• Oral achondroplasia therapy receives FDA breakthrough therapy designation
• Personal CGM use in hospitals feasible, preferred by nurses and patients Michael Monostra
• Progression to overt hypothyroidism more likely with subclinical disease during pregnancy Michael Monostra
• Providers should assess HbA1c and CGM metrics in diabetes management Michael Monostra
• Q&A: International consensus provides guidance for monitoring early-stage type 1 diabetes Jill Rollet
• QWINT: Once-weekly insulin tied to similar HbA1c reduction as insulin degludec Michael Monostra
• Sotagliflozin improves time in range in basal insulin-treated type 2 diabetes Erik Swain
• Tirzepatide cuts risk for progression to type 2 diabetes for adults with prediabetes
• Tubeless insulin patch pump receives FDA clearance for type 1 and type 2 diabetes
• Voice changes, altered by hormone therapy, impact ‘at least one-third’ of menopausal women Erin T. Welsh, MA